Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

NCT01573624 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: FF/GSK573719
DRUG: FF/GSK573719
DRUG: FF/GSK573719
DRUG: FF/GSK573719
DRUG: FF/GSK573719
DRUG: FF
DRUG: FF/VI

Sponsor

GlaxoSmithKline